Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
34 studies found for:    "Typhoid fever"
Show Display Options
Download search resultsDownload the search results for:
"Typhoid fever" (34 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Understanding Typhoid Disease After Vaccination
Conditions: Typhoid Fever;   Enteric Fever;   Typhoid
Interventions: Biological: Vaccine placebo (excipients only);   Biological: Ty21a;   Biological: M10ZH09 vaccine
2 Active, not recruiting Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever
Conditions: Enteric Fever;   Typhoid Fever
Interventions: Drug: Ceftriaxone;   Drug: Gatifloxacin
3 Completed
Has Results
Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants
Condition: Typhoid Fever
Interventions: Biological: Vi-rEPA conjugate vaccine for typhoid fever;   Biological: Hib-TT;   Biological: DTP
4 Completed Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects
Condition: Typhoid Fever
Intervention: Biological: Ty800 (Salmonella typhi) Oral Vaccine
5 Unknown  Typhoid Fever: Combined vs. Single Antibiotic Therapy
Condition: Typhoid Fever
Interventions: Drug: ceftriaxone;   Drug: ceftriaxone and azithromycin;   Drug: azithromycin;   Drug: azithromycin and cefixime
6 Completed
Has Results
Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects
Conditions: Salmonella Infections;   Typhoid Fever;   Bacterial Infections
Intervention: Biological: Typhoid Vi polysaccharide
7 Completed Evaluation of the Vi Polysaccharide Vaccine Against Typhoid Fever
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A vaccine
8 Completed Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Meningococcal A (control)
9 Recruiting Vaccines Against Salmonella Typhi
Conditions: Typhoid Fever;   Enteric Fever
Interventions: Biological: Vi-TCV;   Biological: Vi-PS Vaccine;   Biological: Control (Men ACWY)
10 Recruiting Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study
Conditions: Typhoid Fever;   Paratyphoid Fever
Interventions: Biological: Salmonella Typhi;   Biological: Salmonella Paratyphi
11 Completed Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A (control)
12 Completed Combined Vi Vaccination and Health Education Program on the Burden of Typhoid in Childhood
Conditions: Typhoid;   Paratyphoid Fever
Interventions: Biological: Typhoid Vi vaccine;   Biological: Hepatitis A vaccine
13 Completed CVD 909 Vi Prime Boost Study
Condition: Typhoid Fever
Interventions: Biological: CVD 909;   Drug: Placebo;   Biological: Vi Polysaccharide
14 Not yet recruiting Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
Condition: Typhoid
Interventions: Biological: Vi-DT;   Biological: Typhim Vi®;   Biological: VAXIGRIP®
15 Completed Investigating the Effects of Typhoid Vaccine on Sleep in Healthy Volunteers
Condition: Typhoid Vaccine on Sleep
Interventions: Biological: Typhoid Vaccine;   Biological: Placebo
16 Completed Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults
Condition: Typhoid
Interventions: Biological: M01ZH09;   Other: Placebo
17 Completed
Has Results
Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults
Condition: Typhoid Fever
Intervention: Biological: NVGH Vi-CRM197
18 Completed
Has Results
Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)
Condition: Typhoid Fever
Interventions: Biological: NVGH Vi-CRM197 12.5 mcg;   Biological: NVGH Vi-CRM197 5.0 mcg;   Biological: NVGH Vi-CRM197 1.25 mcg;   Biological: Vi-polysaccharide vaccine
19 Completed
Has Results
Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)
Condition: Typhoid Fever
Interventions: Biological: Typherix;   Biological: NVGH Vi-CRM197
20 Completed Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age
Condition: Typhoid Fever
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Indicates status has not been verified in more than two years